Takeda (NYSE: TAK) Japan Pharma chief details shares, RSUs and tax awards
Rhea-AI Filing Summary
TAKEDA PHARMACEUTICAL CO LTD executive Asuka Miyabashira, President of the Japan Pharma Business Unit, reports direct ownership of 3,000 Ordinary Shares. The position also includes 1,600 restricted stock units (RSUs), which are rights to receive one Ordinary Share each as they vest.
The RSUs vest in tranches of 700 shares on June 1, 2026, 500 shares on June 1, 2027, and 400 shares on June 1, 2028. In addition, Miyabashira holds Tax Obligation Awards that are economically equivalent to Ordinary Shares and are designed to be settled in cash primarily to cover tax obligations at the then-current market price when they vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Miyabashira Asuka
Role
President, Japan Pharma B.U.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Tax Obligation Award | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Tax Obligation Award — 2,260 shares (Direct);
Ordinary Shares — 3,000 shares (Direct)
Footnotes (2)
- F1. Includes 1,600 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (700 shares), June 1, 2027 (500 shares) and June 1, 2028 (400 shares).
- F2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider holdings did Asuka Miyabashira report in Takeda (TAK)?
Asuka Miyabashira reported direct ownership of 3,000 Ordinary Shares of Takeda. The disclosure also notes 1,600 restricted stock units (RSUs) and several Tax Obligation Awards linked to Ordinary Shares, providing a mix of share ownership and equity-based compensation exposure.
How many RSUs does Asuka Miyabashira hold in Takeda (TAK) and how do they vest?
Miyabashira holds 1,600 restricted stock units (RSUs), each linked to one Ordinary Share. These RSUs vest in stages: 700 shares on June 1, 2026, 500 shares on June 1, 2027, and 400 shares on June 1, 2028, subject to the award terms.
What are Tax Obligation Awards reported by Asuka Miyabashira at Takeda (TAK)?
The Tax Obligation Awards are instruments economically equivalent to Ordinary Shares that convert into cash upon vesting. According to the disclosure, the cash payment is intended primarily to cover tax obligations, using the then-current market price of Takeda’s Ordinary Shares as the valuation basis.
What role does Asuka Miyabashira hold at Takeda (TAK) in this ownership report?
In this ownership report, Asuka Miyabashira is identified as an officer of Takeda, serving as President, Japan Pharma Business Unit. The filing ties this leadership role to the detailed disclosure of Ordinary Share holdings, RSUs, and Tax Obligation Awards.